Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- And DHA-1-type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae

Journal of Korean Medical Science

Volumn 20, Issue 6, 2005, Pages 961-965

  Jong, Hwa Yum ^a   Kim, Shinyoung ^a   Lee, Hyukmin ^a   Yong, Dongeun ^a   Lee, Kyungwon ^a,b   Cho, Sang Nae ^b   Chong, Yunsop ^a  

^a Department of Laboratory Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

AmpC beta lactamase; Beta lactamase CMY 2; Beta lactamase CTX M 14; Beta lactamase DHA 1; Klebsiella pneumoniae

Indexed keywords

EID: 31544469770     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.6.961     Document Type: Article

References (20)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
2. Pai H. The characteristics of extended-spectrum β-lactamases in Korean isolates of Enterobacteriaceae. Yonsei Med J 1998; 39: 514-9.
3. Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea. J Clin Microbiol 2001; 39: 3747-9.
4. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17: 316-21.
5. Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC β-lactamases: How far have we gone 10 years after the discovery? Yonsei Med J 1998; 39: 520-5.
6. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
7. Yan JJ, Ko WC, Wu HM, Tsai SH, Chuang CL, Wu JJ. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a Teaching Hospital in Taiwan. J Clin Microbiol 2004; 42: 5337-40.
8. Farmer III JJ. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM, 1999.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. M100-S12. Wayne, PA: NCCLS; 2002.
10. Hong SG, Kim S, Jeong SH, Chang CL, Cho SR, Ahn JY, Shin JH, Lee HS, Song WK, Uh Y, Yum JH, Yong D, Lee K, Chong Y. Prevalence and diversity of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J Clin Microbiol 2003; 6: 149-55.
11. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
12. Lee SH, Jeong SH, Park YM. Characterization of blaCMY-10 a novel, plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes. J Appl Microbiol 2003; 95: 744-52.
13. Lee SH, Kim JY, Lee GS, Cheon SH, An YJ, Jeong SH, Lee KJ. Characterization of blaCMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli. J Antimicrob Chemother 2002; 49: 269-73.
14. Lee K, Jang SJ, Lee HJ, Ryoo N, Kim M, Hong SG, Chong Y. Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. J Korean Med Sci 2004; 19: 8-14.
15. Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H. Characterization of the plasmid β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 1996; 40: 221-4.
16. Poirel L, Heritier C, Spicq C, Nordmann P. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 2004; 42: 3831-3.
17. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41: 563-9.
18. Gaillot O, Clement C, Simonet M, Philippon A. Novel transferable β-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J Antimicrob Chemother 1997; 39: 85-7.
19. Kim JY, Park YJ, Lee SO, Song W, Jeong SH, Yoo YA, Lee KY. Case report: Bacteremia due to Salmonella enterica serotype Montevideo producing plasmid-mediated AmpC beta-lactamase (DHA-1). Ann Clin Lab Sci 2004; 34: 214-7.
20. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW. Epidemiology and clinical features of bloodstream infections caused by AmpC-type- β-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 3720-8.